Revacure Lifesciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 75.00 K
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.85 Cr
- Revenue Growth 362.43%
- Profit Growth 56.63%
- Ebitda 195.62%
- Total Assets -9.70%
About Revacure Lifesciences Llp
Revacure Lifesciences Llp (RLL) is 9 Year, 5 Months old Limited Liability Partnership 17 August 2015. Its registered office is in South Delhi, Delhi, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 75.00 K as per MCA.
Company Details
-
Location
South Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAE-5788
-
Incorporation Date
17 Aug 2015
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Delhi
-
Company Classification
Limited Liability Partnership
Industry
What products or services does Revacure Lifesciences Llp offer?
Revacure Lifesciences Llp offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at Revacure Lifesciences Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeti Bhardwaj
|
Designated Partner | 17-Aug-2015 | Current |
|
Ravi Saxena
|
Designated Partner | 17-Aug-2015 | Current |
|
Rajeev Saxena
|
Designated Partner | 17-Aug-2015 | Current |
Financial Performance of Revacure Lifesciences Llp.
Revacure Lifesciences Llp, for the financial year ended 2020, experienced significant growth in revenue, with a 362.43% increase. The company also saw a substantial improvement in profitability, with a 56.63% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Revacure Lifesciences Llp?
Unlock access to Revacure Lifesciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cgmp Pharma 'N' Plans Private LimitedRavi Saxena and Neeti Bhardwaj are mutual person
Charges (Loans)
₹98,500,000.00
₹0
Charges Breakdown by Lending Institutions
- Allahabad Bank : 9.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2016 | Allahabad Bank | ₹9.85 Cr | Open |
How Many Employees Work at Revacure Lifesciences Llp?
Revacure Lifesciences Llp has a workforce of 12 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Revacure Lifesciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revacure Lifesciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.